Capricor Therapeutics
CAPR
#7984
Rank
ยฃ0.21 B
Marketcap
ยฃ4.77
Share price
-4.36%
Change (1 day)
-59.68%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ31.92 Million

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are ยฃ31.92 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ19.93 M-29.71%
2023-12-31ยฃ28.36 M-10.43%
2022-12-31ยฃ31.66 M329.05%
2021-12-31ยฃ7.38 M56.72%
2020-12-31ยฃ4.7 M44.48%
2019-12-31ยฃ3.25 M-10.67%
2018-12-31ยฃ3.64 M-2.29%
2017-12-31ยฃ3.73 M-79.75%
2016-12-31ยฃ18.43 M59.77%
2015-12-31ยฃ11.53 M-9.63%
2014-12-31ยฃ12.76 M246.85%
2013-12-31ยฃ3.68 M1024.5%
2012-12-31ยฃ0.32 M-6.02%
2011-12-31ยฃ0.34 M-49.7%
2010-12-31ยฃ0.69 M75.78%
2009-12-31ยฃ0.39 M-56.64%
2008-12-31ยฃ0.9 M-4.45%
2007-12-31ยฃ0.95 M1282.2%
2006-12-31ยฃ0.06 M52.31%
2005-12-31ยฃ0.04 M46.01%
2004-12-31ยฃ0.03 M32.52%
2003-12-31ยฃ0.02 M52.46%
2002-12-31ยฃ0.01 M141.73%
2001-12-31ยฃ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
ยฃ1.46 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ7.58 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.13 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.94 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ37.54 M 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ1.95 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA